Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Memo - Magazine of European Medical Oncology is Scopus-indexed (Q3, CiteScore 1.2), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer.
Checked against the index lists dated .
ISSN 1865-5041Verify ISSN ↗1865-5076Verify ISSN ↗
Publisher: Springer
Cost to publish: About US$4,790 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Hematology | 112 / 151 | 26th | Q3 |
| Oncology | 322 / 428 | 24th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q3, CiteScore 1.2.
Memo - Magazine of European Medical Oncology is Q3 in Hematology (rank 112 of 151) and Q4 in Oncology (rank 322 of 428), by CiteScore 2025.
Memo - Magazine of European Medical Oncology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.2, which places it in quartile Q3 at the 26th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.281, quartile Q4, with an H-index of 25.
The publisher lists an article processing charge of about US$4,790 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Memo - Magazine of European Medical Oncology is published by Springer. Its print ISSN is 1865-5041 and its online ISSN is 1865-5076.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Memo - Magazine of European Medical Oncology has an h-index of 26 and a 2-year mean of 0.77 citations per paper (OpenAlex). Its Scopus CiteScore is 1.2, quartile Q3. On 2-year citations it ranks #102 of 148 Scopus journals in Hematology.
Memo - Magazine of European Medical Oncology published 75 papers in 2025; its busiest recent year was 2020 with 116. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2025–2026), authors are most often from Austria (77.9%), Germany (5.4%) and Japan (3.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.